Please see the full advisory for more information, including what Canadians should do and Health Canada’s work to address the issue of azido impurities found in certain drugs.
| Samfur | Kamfanin | DIN | Lutu | Iryarshe |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETS | Mint Pharmaceuticals Inc. | 02389657 | 2005006959 | Afrilu 2023 |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETS | Mint Pharmaceuticals Inc. | 02389657 | 2005006960 | Afrilu 2023 |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETS | Mint Pharmaceuticals Inc. | 02389657 | 2005006961 | Afrilu 2023 |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETS | Mint Pharmaceuticals Inc. | 02389657 | 2005006962 | Afrilu 2023 |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETS | Mint Pharmaceuticals Inc. | 02389657 | 2005006963 | Afrilu 2023 |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETS | Mint Pharmaceuticals Inc. | 02389657 | 2005011154 | Yuni 2023 |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETS | Mint Pharmaceuticals Inc. | 02389657 | 2005011156 | Yuni 2023 |
| MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETS | Mint Pharmaceuticals Inc. | 02389665 | 2005006807 | Afrilu 2022 |
| MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETS | Mint Pharmaceuticals Inc. | 02389665 | 2005006808 | Afrilu 2022 |
| MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETS | Mint Pharmaceuticals Inc. | 02389665 | 2005006809 | Afrilu 2022 |
| MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETS | Mint Pharmaceuticals Inc. | 02389665 | 2005006810 | Afrilu 2022 |
| MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETS | Mint Pharmaceuticals Inc. | 02389665 | 2105002149 | Disamba 2022 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 1805012687 | Oktoba 2021 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 1805012688 | Oktoba 2021 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 1805012689 | Oktoba 2021 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 1805012792 | Oktoba 2021 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 1905001010 | Disamba 2021 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 1905001011 | Disamba 2021 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 2005006947 | Afrilu 2023 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 2005006949 | Afrilu 2023 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 2005006950 | Afrilu 2023 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 2005006951 | Afrilu 2023 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 2005007297 | Afrilu 2023 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 2005007298 | Afrilu 2023 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 2005013776 | Agusta 2023 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 2105002150 | Disamba 2023 |
ABUBUWAN DA ZA KU GUDU DAGA WANNAN LABARI:
- 023896732005006947April 2023MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.
- 023896732005006949April 2023MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.
- 023896732005006950April 2023MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.
